Keyvantage Wealth’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
DGM
BBA
Keyvantage Wealth's INSM Position: Q1 2026 in Review
Keyvantage Wealth sold out of Insmed (INSM) in Q1 2026, closing a stake of 1,163 shares — an estimated $202K sold.
Keyvantage Wealth first reported a position in INSM in Q4 2025 and held it in 1 quarter. The position peaked at $202K in Q4 2025. 674 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Keyvantage Wealth reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
- Keyvantage Wealth sold 1,163 Insmed shares in Q1 2026, an estimated $202K.
- Keyvantage Wealth first reported a position in Insmed in Q4 2025 and held it in 1 quarter.
- Keyvantage Wealth's Insmed position peaked at $202K in Q4 2025.
- 674 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Keyvantage Wealth's 13F filing for Q1 2026, filed 5 May 2026.